文献速递消化道肿瘤放疗

胰腺腺癌的放射治疗:一种在难治性恶性肿瘤管理中必须考虑的治疗选择

Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy.
PubMed 文献 · Radiat Oncol · 2019-06-26

本文综述了放射治疗在可切除、交界可切除和不可切除胰腺腺癌中的治疗依据。胰腺腺癌的临床结局仍然很差,局部复发、切缘阳性手术切除比例和总生存结局均劣于其他实体瘤。放射治疗历史上是胰腺腺癌治疗的核心组成部分,但基于结果矛盾的临床试验发表,其作用受到质疑。本文进一步总结了新兴临床数据和未来方向以改善这种难治性恶性肿瘤的结局。

要点

  • 胰腺腺癌的局部复发、切缘阳性率和总生存均劣于其他实体瘤。
  • 放射治疗历史上是胰腺腺癌治疗的核心组成部分。
  • 基于结果矛盾的临床试验,放射治疗的作用受到质疑。

核心结论

  • 胰腺腺癌的临床结局仍然很差,放射治疗的作用虽受质疑但必须被考虑。
  • 需要以现代治疗技术和新型治疗选择来启发和转变当前的标准治疗管理方法。

研究设计与样本

  • 本文为综述,概述了放射治疗在可切除、交界可切除和不可切除胰腺腺癌中的依据。
  • 本文总结了新兴临床数据和未来方向。

主要发现

  • 胰腺腺癌的局部复发、切缘阳性手术切除比例和总生存结局均劣于其他实体瘤。
  • 基于结果矛盾的临床试验发表,放射治疗的作用受到质疑。

临床怎么用

  • 在胰腺腺癌管理中应考虑放射治疗作为治疗选择。
  • 需要以现代治疗技术和新型治疗选择来转变当前的标准治疗管理方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical outcomes for patients with pancreatic adenocarcinoma (PAC) remain dismal. Local recurrences, proportions of margin positive surgical resections, and overall survival outcomes remain inferior in PAC than any other solid tumor. This stems from a current standard of care management approach that needs to be inspired and transformed with modern treatment techniques and novel therapeutic options. Radiation therapy has historically been a central component in the treatment of pancreatic adenocarcinoma; however, the role of radiation therapy has been called into question based on the publication of clinical trials with conflicting results. We present an overview of the rationale for radiation therapy in resectable, borderline resectable, and unresectable pancreatic adenocarcinoma. We further present a summary of emerging clinical data and future directions to improve outcomes in this devastating malignancy.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Hall WA, Goodman KA. Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy. Radiat Oncol. 2019. PMID: 31242912. doi:10.1186/s13014-019-1277-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。